The ICMR is undertaking a study in Mumbai to evaluate whether the Bacille Calmette- Guerin vaccine, primarily used against tuberculosis, is effective in preventing Covid-19 in elderly population, the city civic body said on Friday.
The Brihanmumbai Municipal Corporation said that Seth GS Medical College, civic-run KEM Hospital and the public health department of the BMC will jointly conduct the study for the Indian Council of Medical Research.
“The study will also look at degree of severity of the disease and development of immunity using immunological markers,” the BMC said.
The civic body said there is evidence to suggest that the BCG vaccine, normally given to children for immunity against tuberculosis, has protective effect against other respiratory tract infections, including viral diseases.
According to the BMC, the study will include elderly individuals between 60-75 years of age who have not suffered from Covid-19, do not have cancer and are not immunocompromised (having a weak immune system).
“Necessary approval for the trial has been obtained,” it said.
ICMR has undertaken similar studies in Covid-19 hotspots in multiple cities, including Chennai, Ahmedabad, Bhopal, Jodhpur and New Delhi.
Source: PTI